PFE
Pfizer Inc.
- Operating cash flow, 2025
- $11.7B
- YoY, 2025
- −8.2%
- 5-year CAGR
- −4.1%
- 10-year CAGR
- −2.2%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $11.7B | −8.2% |
| 2024 | $12.7B | +46.5% |
| 2023 | $8.7B | −70.3% |
| 2022 | $29.3B | −10.2% |
| 2021 | $32.6B | +126.2% |
| 2020 | $14.4B | +14.4% |
| 2019 | $12.6B | −20.5% |
| 2018 | $15.8B | −5.8% |
| 2017 | $16.8B | +3.8% |
| 2016 | $16.2B | +10.2% |
| 2015 | $14.7B | −14.0% |
| 2014 | $17.1B | −3.4% |
| 2013 | $17.7B | +5.6% |
| 2012 | $16.7B | −17.3% |
| 2011 | $20.2B | +76.7% |
| 2010 | $11.5B | −30.9% |
| 2009 | $16.6B | −9.1% |
| 2008 | $18.2B | +36.6% |
| 2007 | $13.4B | — |